Elanco Animal Health Incorporated

NYSE ELAN

Elanco Animal Health Incorporated Dividends Paid for the Trailing 12 Months (TTM) ending September 30, 2024: USD 0.00

Elanco Animal Health Incorporated Dividends Paid is USD 0.00 for the Trailing 12 Months (TTM) ending September 30, 2024, a 0.00% change year over year. Dividends paid is cash paid to shareholders as a distribution of profits.
  • Elanco Animal Health Incorporated Dividends Paid for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 0.00, a 0.00% change year over year.
  • Elanco Animal Health Incorporated Dividends Paid for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 0.00, a 0.00% change year over year.
  • Elanco Animal Health Incorporated Dividends Paid for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 0.00, a 0.00% change year over year.
  • Elanco Animal Health Incorporated Dividends Paid for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 0.00, a 0.00% change year over year.
Key data
Date Dividends Paid Capital Expenditure Other Financing Activities Net Cash Used Provided By Financing Activities
Market news
Loading...
SV Wall Street
NYSE: ELAN

Elanco Animal Health Incorporated

CEO Mr. Jeffrey N. Simmons
IPO Date Sept. 20, 2018
Location United States
Headquarters 2500 Innovation Way
Employees 9,300
Sector Consumers Staples
Industries
Description

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Similar companies

ITCI

Intra-Cellular Therapies, Inc.

USD 127.08

0.06%

ESPR

Esperion Therapeutics, Inc.

USD 1.79

-1.10%

SIGA

SIGA Technologies, Inc.

USD 5.98

-2.92%

IRWD

Ironwood Pharmaceuticals, Inc.

USD 2.34

1.74%

ALKS

Alkermes plc

USD 31.53

-1.19%

PCRX

Pacira BioSciences, Inc.

USD 26.33

0.34%

LNTH

Lantheus Holdings, Inc.

USD 92.51

-0.30%

PBH

Prestige Consumer Healthcare Inc.

USD 76.77

-2.10%

PAHC

Phibro Animal Health Corporation

USD 21.81

-0.77%

VTRS

Viatris Inc.

USD 11.28

-1.23%

COLL

Collegium Pharmaceutical, Inc.

USD 32.12

-1.20%

StockViz Staff

February 2, 2025

Any question? Send us an email